Maria Celeste Cano Counselor Medicare: Not Enrolled in Medicare Practice Location: 53 Eagle St, Pittsfield, MA 01201 Phone: 413-629-1403 |
Natlie Lewis Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 Fenn St, Administrative Offices, Pittsfield, MA 01201 Phone: 413-629-1262 Fax: 413-448-2198 |
Kelly Anne Bodnar Counselor Medicare: Not Enrolled in Medicare Practice Location: 877 South St, Suite Number 300, Pittsfield, MA 01201 Phone: 413-236-5656 |
Ms. Lindsey Cavallero, LMHC ATR Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 333 East St, Pittsfield, MA 01201 Phone: 413-629-1159 |
April Gardner Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 Fenn St, Administrative Offices, Pittsfield, MA 01201 Phone: 413-499-0412 Fax: 413-448-2198 |
Maria Ahlin Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 Fenn St, Pittsfield, MA 01201 Phone: 413-499-0412 Fax: 413-448-2198 |
Jennifer Godyn Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Fenn St, Brien Center, Pittsfield, MA 01201 Phone: 413-629-1253 |
Kelly Kozik Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 Fenn St, Administrative Offices, Pittsfield, MA 01201 Phone: 413-629-1262 Fax: 413-448-2198 |
Christina Rotolo Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 Fenn St, Administrative Offices, Pittsfield, MA 01201 Phone: 413-629-1262 Fax: 413-448-2198 |
Olga Kim Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 Fenn St, Administrative Offices, Pittsfield, MA 01201 Phone: 413-629-1251 Fax: 413-448-2198 |
Rebecca Gillespie Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 Fenn St, Pittsfield, MA 01201 Phone: 413-629-1262 Fax: 413-448-2198 |
Jessica May Loebel, BA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 877 South St, Pittsfield, MA 01201 Phone: 413-236-5656 |
Mr. Carl J. Gigliotti, M.A. CLINICAL PSYCH. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 48 Lexington Pkwy, Pittsfield, MA 01201 Phone: 413-499-6611 |
Kimberly Ann Sawyer Counselor Medicare: Not Enrolled in Medicare Practice Location: 53 Eagle St, Pittsfield, MA 01201 Phone: 413-236-5656 |
Charles Osei Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 Fenn St, Administrative Offices, Pittsfield, MA 01201 Phone: 413-629-1262 Fax: 413-448-2198 |
Scott Johnston Steele, MSW Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 333 East St, Brien Center, Pittsfield, MA 01201 Phone: 413-499-0412 Fax: 413-499-0979 |
Jessica Bortolotto Counselor Medicare: Not Enrolled in Medicare Practice Location: 251 Fenn St, Brien Center, Pittsfield, MA 01201 Phone: 413-629-1253 |
Ms. Patricia Ann Vint, MHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 53 Eagle St, Pittsfield, MA 01201 Phone: 413-236-5656 |
Sena Larabee, M.S.ED. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 53 Eagle St, Pittsfield, MA 01201 Phone: 413-236-5656 |
Ms. Colleen Rebecca Jordan, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 75 S Church St, 6th Floor Suite 6, Pittsfield, MA 01201 Phone: 413-358-4757 |
News Archive
Warwick Medical School has just begun a -2.6 million three year research and training programme to train Malawian clinical officers in a bid to reduce the country's high death rate for pregnant mothers and babies.
More than 50 million people in the United States suffer from pain in the absence of injury. This includes patients with migraines, fibromyalgia, irritable bowel syndrome and many other disorders.
A mutation in a gene commonly associated with deafness can play an important part in improving wound healing, a scientist told the annual conference of the European Society of Human Genetics in Amsterdam, The Netherlands.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
› Verified 8 days ago